Yaral Pharma
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8 Campus Dr Ste 201A, Parsippany, New Je...Phone Number
(866) 218-9009Website
www.yaral-pharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Yaral Pharma
Yaral Pharma is the generics division of IBSA Pharma, they are dedicated to ensuring access to affordable authorized generics (AGs) and complex generic medicines that enhance healthcare outcomes. The company is based in Parsippany, New Jersey.Explore more
Yaral Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Yaral Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Yaral Pharma is spiking on competitors!
Funding: Get notified immidiatlly once Yaral Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Yaral Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Yaral Pharma launches new products
Click to see if Yaral Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Yaral Pharma recently announced quarterly report
Yaral Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Yaral Pharma
Recommended Actions
Find VP level buyers at Yaral Pharma
Find 3 more new buyers
Compare Similar Companies to Yaral Pharma
Compare insights from companies similar to Yaral Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Yaral Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Yaral Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Yaral Pharma.
Yaral Pharma Tech Stack
A closer look at the technologies used by Yaral Pharma
Most Recent Scoops
Award
Award, Logistics / Supply Chain, Pharmaceuticals, Operations
Product Launch
Product Development, Product Launch, Product Management
New Hire
Executive Move
Yaral Pharma has announced that Roberto Marrero-Marrero has joined the organization as Chief Financial Officer.
New Hire
Executive Move
Yaral Pharma News & Media
Yaral Pharma becomes exclusive supplier of authorized generic levothyroxine sodium capsules
Levothyroxine Sodium Capsules are used to treat hypothyroidism.YARAL Pharma Marks Its First Anniversary
PARSIPPANY, N.J.--(BUSINESS WIRE)--YARAL Pharma Inc., (YARAL Pharma) is proud to celebrate the first anniversary of its entry into the United States generics marketplace. YARAL Pharma is the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a distinguished multinational pharmaceutical company headquartered in Lugano, Switzerland. During its first year, the company has consistently lived up to its mission of delivering affordable, high-quality authorized and complex generic medicationsYaral Pharma Partners With EVERSANA to Support the Commercialization of Its Expanding Generics Portfolio
PARSIPPANY, N.J.--(BUSINESS WIRE)--Yaral Pharma Inc., (Yaral Pharma) the United States generics subsidiary of IBSA (Institut Biochimique SA), today announced its expanding partnership with EVERSANA®, a leading provider of commercialization services to the global life sciences industry, as its key commercialization partner to support the expansion of its portfolio of pain and endocrinology products in the U.S. EVERSANA will provide a full range of services including, but not limited to, third-paYaral Pharma launches generic Flector
Diclofenac epolamine topical system 1.3% is a prescription nonsteroidal anti-inflammatory medicated patch indicated for the topical treatment of acute pain due to minor strains, sprains and contusions.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Yaral Pharma
Sign Up For FreeTo access detailed company insights
Yaral Pharma is the generics division of IBSA Pharma, they are dedicated to ensuring access to affordable authorized generics (AGs) and complex generic medicines that enhance healthcare outcomes. The company is based in Parsippany, New Jersey.... Read More
